[Therapeutic drug monitoring of antituberculosis drugs].
Goromaru
T
T
Department of Radiopharmaceutical Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, University of Fukuyama.
D000367:Age Factors; D010131:Aminosalicylic Acid / Q000493:pharmacokinetics; D000995:Antitubercular Agents / Q000493:pharmacokinetics*; D001682:Biological Availability; D004304:Dosage Forms; D004347:Drug Interactions; D006801:Humans; D007538:Isoniazid / Q000493:pharmacokinetics; D007674:Kidney Diseases / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism; D012293:Rifampin / Q000493:pharmacokinetics; D013307:Streptomycin / Q000493:pharmacokinetics
D000995:Antitubercular Agents; D004304:Dosage Forms; D010131:Aminosalicylic Acid; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin